APO Research
Talk to an analyst

APO RESEARCH · REPORT

Milrinone Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Milrinone Injection Market Outlook and Growth Opportunities 2026

30 December 2025192 pages

Choose your research edition.

Industry ResearchMilrinone Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Milrinone Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Milrinone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Milrinone Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Milrinone Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Milrinone Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Milrinone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Milrinone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Milrinone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Milrinone Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Milrinone Injection market include Haini, NJCTTQ, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd, LUNANLIKANG, SaiLong and PKU HealthCare Corp,.Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Milrinone Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Milrinone Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Milrinone Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Milrinone Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Milrinone Injection Segment by Company

Haini

NJCTTQ

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

LUNANLIKANG

SaiLong

PKU HealthCare Corp,.Ltd.

Milrinone Injection Segment by Type

0.98

0.99

Others

Milrinone Injection Segment by Application

Medical

Others

Milrinone Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Milrinone Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Milrinone Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Milrinone Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Milrinone Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Milrinone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Milrinone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Milrinone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Milrinone Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Milrinone Injection industry.

Chapter 3: Detailed analysis of Milrinone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Milrinone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Milrinone Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Milrinone Injection Industry Trends Table 2. Milrinone Injection Industry Drivers Table 3. Milrinone Injection Industry Opportunities and Challenges Table 4. Milrinone Injection Industry Restraints Table 5. Global Milrinone Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Milrinone Injection Revenue Share by Company (2021-2026) Table 7. Global Milrinone Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Milrinone Injection Sales Volume Share by Company (2021-2026) Table 9. Global Milrinone Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Milrinone Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Milrinone Injection Key Company Manufacturing Base & Headquarters Table 12. Global Milrinone Injection Company, Product Type & Application Table 13. Global Milrinone Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Milrinone Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.98 Table 18. Significant Companies of 0.99 Table 19. Significant Companies of Others Table 20. Global Milrinone Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Milrinone Injection Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Milrinone Injection Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Milrinone Injection Sales Volume Share by Type (2021-2026) Table 24. Global Milrinone Injection Sales Volume Share by Type (2027-2032) Table 25. Global Milrinone Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Milrinone Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Milrinone Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Milrinone Injection Sales Value Share by Type (2021-2026) Table 29. Global Milrinone Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Medical Table 31. Significant Companies of Others Table 32. Global Milrinone Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Milrinone Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Milrinone Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Milrinone Injection Sales Volume Share by Application (2021-2026) Table 36. Global Milrinone Injection Sales Volume Share by Application (2027-2032) Table 37. Global Milrinone Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Milrinone Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Milrinone Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Milrinone Injection Sales Value Share by Application (2021-2026) Table 41. Global Milrinone Injection Sales Value Share by Application (2027-2032) Table 42. Global Milrinone Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Milrinone Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Milrinone Injection Sales Market Share by Region (2021-2026) Table 45. Global Milrinone Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Milrinone Injection Sales Market Share by Region (2027-2032) Table 47. Global Milrinone Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Milrinone Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Milrinone Injection Sales Value Share by Region (2021-2026) Table 50. Global Milrinone Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Milrinone Injection Sales Value Share by Region (2027-2032) Table 52. Global Milrinone Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Milrinone Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Milrinone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Milrinone Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Milrinone Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Milrinone Injection Sales Market Share by Country (2021-2026) Table 58. Global Milrinone Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Milrinone Injection Sales Market Share by Country (2027-2032) Table 60. Global Milrinone Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Milrinone Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Milrinone Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Milrinone Injection Sales Value Market Share by Country (2027-2032) Table 64. Haini Company Information Table 65. Haini Business Overview Table 66. Haini Milrinone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Haini Milrinone Injection Product Portfolio Table 68. Haini Recent Development Table 69. NJCTTQ Company Information Table 70. NJCTTQ Business Overview Table 71. NJCTTQ Milrinone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. NJCTTQ Milrinone Injection Product Portfolio Table 73. NJCTTQ Recent Development Table 74. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Company Information Table 75. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Business Overview Table 76. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Product Portfolio Table 78. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Recent Development Table 79. LUNANLIKANG Company Information Table 80. LUNANLIKANG Business Overview Table 81. LUNANLIKANG Milrinone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. LUNANLIKANG Milrinone Injection Product Portfolio Table 83. LUNANLIKANG Recent Development Table 84. SaiLong Company Information Table 85. SaiLong Business Overview Table 86. SaiLong Milrinone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. SaiLong Milrinone Injection Product Portfolio Table 88. SaiLong Recent Development Table 89. PKU HealthCare Corp,.Ltd. Company Information Table 90. PKU HealthCare Corp,.Ltd. Business Overview Table 91. PKU HealthCare Corp,.Ltd. Milrinone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. PKU HealthCare Corp,.Ltd. Milrinone Injection Product Portfolio Table 93. PKU HealthCare Corp,.Ltd. Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Milrinone Injection Distributors List Table 97. Milrinone Injection Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Milrinone Injection Product Image Figure 2. Global Milrinone Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Milrinone Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Milrinone Injection Sales (2021-2032) & (K Units) Figure 5. Global Milrinone Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Milrinone Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.98 Image Figure 10. 0.99 Image Figure 11. Others Image Figure 12. Global Milrinone Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Milrinone Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Milrinone Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Milrinone Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Milrinone Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Milrinone Injection Sales Value Share by Type (2021-2032) Figure 18. Medical Image Figure 19. Others Image Figure 20. Global Milrinone Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Milrinone Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Milrinone Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Milrinone Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Milrinone Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Milrinone Injection Sales Value Share by Application (2021-2032) Figure 26. Global Milrinone Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Milrinone Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Milrinone Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Milrinone Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Milrinone Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Milrinone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Milrinone Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Milrinone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Milrinone Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Milrinone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Milrinone Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Milrinone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Milrinone Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Milrinone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Milrinone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Milrinone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Milrinone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Milrinone Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Milrinone Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 0.98
  • 0.99
  • Others
Applications
  • Medical
  • Others
Companies covered
  • Haini
  • NJCTTQ
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
  • LUNANLIKANG
  • SaiLong
  • PKU HealthCare Corp,.Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Milrinone Injection Sales Value (2021-2032)
  4. 1.2.2 Global Milrinone Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Milrinone Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Milrinone Injection Market Dynamics
  1. 2.1 Milrinone Injection Industry Trends
  2. 2.2 Milrinone Injection Industry Drivers
  3. 2.3 Milrinone Injection Industry Opportunities and Challenges
  4. 2.4 Milrinone Injection Industry Restraints
3 Milrinone Injection Market by Company
  1. 3.1 Global Milrinone Injection Company Revenue Ranking in 2025
  2. 3.2 Global Milrinone Injection Revenue by Company (2021-2026)
  3. 3.3 Global Milrinone Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Milrinone Injection Average Price by Company (2021-2026)
  5. 3.5 Global Milrinone Injection Company Ranking (2024-2026)
  6. 3.6 Global Milrinone Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Milrinone Injection Company Product Type and Application
  8. 3.8 Global Milrinone Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Milrinone Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Milrinone Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Milrinone Injection Market by Type
  1. 4.1 Milrinone Injection Type Introduction
  2. 4.1.1 0.98
  3. 4.1.2 0.99
  4. 4.1.3 Others
  5. 4.2 Global Milrinone Injection Sales Volume by Type
  6. 4.2.1 Global Milrinone Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Milrinone Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Milrinone Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Milrinone Injection Sales Value by Type
  10. 4.3.1 Global Milrinone Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Milrinone Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Milrinone Injection Sales Value Share by Type (2021-2032)
5 Milrinone Injection Market by Application
  1. 5.1 Milrinone Injection Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Others
  4. 5.2 Global Milrinone Injection Sales Volume by Application
  5. 5.2.1 Global Milrinone Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Milrinone Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Milrinone Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Milrinone Injection Sales Value by Application
  9. 5.3.1 Global Milrinone Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Milrinone Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Milrinone Injection Sales Value Share by Application (2021-2032)
6 Milrinone Injection Regional Sales and Value Analysis
  1. 6.1 Global Milrinone Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Milrinone Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Milrinone Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Milrinone Injection Sales by Region (2027-2032)
  5. 6.3 Global Milrinone Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Milrinone Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Milrinone Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Milrinone Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Milrinone Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Milrinone Injection Sales Value (2021-2032)
  12. 6.6.2 North America Milrinone Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Milrinone Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Milrinone Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Milrinone Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Milrinone Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Milrinone Injection Sales Value (2021-2032)
  21. 6.9.2 South America Milrinone Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Milrinone Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Milrinone Injection Sales Value Share by Country, 2025 VS 2032
7 Milrinone Injection Country-level Sales and Value Analysis
  1. 7.1 Global Milrinone Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Milrinone Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Milrinone Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Milrinone Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Milrinone Injection Sales by Country (2027-2032)
  6. 7.4 Global Milrinone Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Milrinone Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Milrinone Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Milrinone Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Milrinone Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Milrinone Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Milrinone Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Milrinone Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Milrinone Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Milrinone Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Milrinone Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Milrinone Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Milrinone Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Milrinone Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Milrinone Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Milrinone Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Milrinone Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Milrinone Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Milrinone Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Milrinone Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Milrinone Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Milrinone Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Milrinone Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Milrinone Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Milrinone Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Milrinone Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Milrinone Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Milrinone Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Milrinone Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Milrinone Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Milrinone Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Milrinone Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Milrinone Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Milrinone Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Haini
  2. 8.1.1 Haini Company Information
  3. 8.1.2 Haini Business Overview
  4. 8.1.3 Haini Milrinone Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Haini Milrinone Injection Product Portfolio
  6. 8.1.5 Haini Recent Developments
  7. 8.2 NJCTTQ
  8. 8.2.1 NJCTTQ Company Information
  9. 8.2.2 NJCTTQ Business Overview
  10. 8.2.3 NJCTTQ Milrinone Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 NJCTTQ Milrinone Injection Product Portfolio
  12. 8.2.5 NJCTTQ Recent Developments
  13. 8.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
  14. 8.3.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Company Information
  15. 8.3.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Business Overview
  16. 8.3.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Product Portfolio
  18. 8.3.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Recent Developments
  19. 8.4 LUNANLIKANG
  20. 8.4.1 LUNANLIKANG Company Information
  21. 8.4.2 LUNANLIKANG Business Overview
  22. 8.4.3 LUNANLIKANG Milrinone Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 LUNANLIKANG Milrinone Injection Product Portfolio
  24. 8.4.5 LUNANLIKANG Recent Developments
  25. 8.5 SaiLong
  26. 8.5.1 SaiLong Company Information
  27. 8.5.2 SaiLong Business Overview
  28. 8.5.3 SaiLong Milrinone Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SaiLong Milrinone Injection Product Portfolio
  30. 8.5.5 SaiLong Recent Developments
  31. 8.6 PKU HealthCare Corp,.Ltd.
  32. 8.6.1 PKU HealthCare Corp,.Ltd. Company Information
  33. 8.6.2 PKU HealthCare Corp,.Ltd. Business Overview
  34. 8.6.3 PKU HealthCare Corp,.Ltd. Milrinone Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PKU HealthCare Corp,.Ltd. Milrinone Injection Product Portfolio
  36. 8.6.5 PKU HealthCare Corp,.Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Milrinone Injection Value Chain Analysis
  2. 9.1.1 Milrinone Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Milrinone Injection Sales Mode & Process
  6. 9.2 Milrinone Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Milrinone Injection Distributors
  9. 9.2.3 Milrinone Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst